Results 191 to 200 of about 580,692 (357)
Reseña de: "LET THEM EAT PROZAC. THE UNHEALTHY RELATIONSHIPBETWEEN THE PHARMACEUTICAL INDUSTRY AND DEPRESSION." de David Healy [PDF]
Alberto Ortiz Lobo
openalex
Theory‐Guided Design of Non‐Precious Single‐Atom Catalyst for Electrocatalytic Chlorine Evolution
To overcome the reliance on noble metals for the chlorine evolution reaction (CER), we designed a non‐precious single‐atom catalyst (SAC), NiN3O–O. It achieves a low overpotential of 75 mV, 95.8% Cl2 selectivity, and outperforms commercial dimensionally stable anodes (DSAs).
Kai Ma +9 more
wiley +1 more source
Network Analysis of the Organic Chemistry in Patents, Literature, and Pharmaceutical Industry. [PDF]
Svensson E +7 more
europepmc +1 more source
This study introduces a novel chloro boron subphthalocyanine/polymer blend OFET sensor achieving 0.005 ppb limit of detection for ammonia at room temperature and high selectivity against similar amines. An original theoretical framework is proposed to describe the sensing mechanism, relating analyte molecular volume and Lewis basicity to sensor ...
Kavinraaj Ella Elangovan +6 more
wiley +1 more source
Leveraging Artificial Intelligence for Advancements in Liquid Dosage Formulations in the Pharmaceutical Industry. [PDF]
Nithyanantham D, Nair A, Nayak UY.
europepmc +1 more source
Alumina growth narrows surface pores and seals non‐selective defects, enhancing selectivity while preserving the nanoporous graphene architecture. Additionally, the deposition enables gradient‐controlled structural modification, with intergrown alumina acting as a physical cross‐linker that stabilizes the laminar structure.
Junhyeok Kang +8 more
wiley +1 more source
Nigeria's Pharmaceutical Industry: Addressing Over-Reliance on Importation and Proposing Sustainable Solutions. [PDF]
Ololade Atanda D +3 more
europepmc +1 more source
The Interplay between Innovation and Marketing: Evidence from the Pharmaceutical Industry
Ce Shi, Yucong Zhao
openalex +1 more source

